Prototype of Innovative Food Product to Improve Respiratory and Peripheral Muscle Function in Humans

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 30, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2021

Conditions
Respiratory Function LossSarcopenia
Interventions
OTHER

innovative nutraceutical-type food product that we designed called HIC1® from coffee mucilage

All participants completed a survey on sociodemographic data (age, sex, respiratory problems, smoking, among others). Weight, height, skin folds, and a blood sample were taken to quantify the Oxygen Radical Absorption Capacity (ORAC) units, amino acids, vitamin B12, vitamin D, phosphorus, magnesium, calcium, and lipid profile. At that time, they were explained how they should eat the nutraceutical food, starting the next day and for five consecutive days. During those 5 days, a nurse made contact calls to verify that the participant took the corresponding dose for the day. After 5 days of ingesting the nutraceutical compound, a blood sample was taken again to quantify post-ingestion levels of ORAC units, amino acids, vitamin B12, vitamin D, phosphorus, magnesium, calcium, and the lipid profile. In the case of the participants in the ICU, control visits were made to the unit to verify that the dose was delivered to the participant

Trial Locations (1)

681004

Fundación Cardiovascular de Colombia, Floridablanca

All Listed Sponsors
collaborator

Sanadores Ambientales SANAM Company SAS

UNKNOWN

lead

Fundación Cardiovascular de Colombia

OTHER

NCT06248437 - Prototype of Innovative Food Product to Improve Respiratory and Peripheral Muscle Function in Humans | Biotech Hunter | Biotech Hunter